Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2023 Aug 30;27(24):4219. doi: 10.1111/jcmm.17909

Correction to Dual deficiency of angiotensin‐converting enzyme‐2 and Mas receptor enhances angiotensin II‐induced hypertension and hypertensive nephropathy

PMCID: PMC10768729  PMID: 37649217

In Jun Ni et al., 1 the grant number of Shanghai Municipal Health Commission was incorrect. It should have been corrected from 202040117 to 202040119. The correct funding information and acknowledgements are shown below.

ACKNOWLEDGEMENTS

This study was supported by grants from the Lui Che Woo Institute of Innovative Medicine (CARE program); Research Grants Council of Hong Kong (GRF 14117418, C7018‐16G, R4012‐18); the Health and Medical Research Fund of Hong Kong (HMRF 05161326, 14152321); the Guangdong‐Hong Kong‐Macao‐Joint Labs Program from Guangdong Science and Technology Department (2019B121205005); National Natural Science Foundation of China (81700672); Shanghai Municipal Health Commission (202040119); Shanghai Jiao Tong University (KJ3‐0214‐19‐0011); German Research Foundation (DFG SFB1365).

REFERENCE

  • 1. Ni J, Yang FY, Huang XR, et al. Dual deficiency of angiotensin‐converting enzyme‐2 and Mas receptor enhances angiotensin II‐induced hypertension and hypertensive nephropathy. J Cell Mol Med. 2020;24:13093‐13103. doi: 10.1111/jcmm.15914 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES